PL405046A1 - Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie - Google Patents

Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie

Info

Publication number
PL405046A1
PL405046A1 PL405046A PL40504613A PL405046A1 PL 405046 A1 PL405046 A1 PL 405046A1 PL 405046 A PL405046 A PL 405046A PL 40504613 A PL40504613 A PL 40504613A PL 405046 A1 PL405046 A1 PL 405046A1
Authority
PL
Poland
Prior art keywords
mmp
activity
biosensor
fret
application
Prior art date
Application number
PL405046A
Other languages
English (en)
Inventor
Michał Stawarski
Jakub Włodarczyk
Leszek Kaczmarek
Original Assignee
Instytut Biologii Doświadczalnej Im. Marcelego Nenckiego Pan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biologii Doświadczalnej Im. Marcelego Nenckiego Pan filed Critical Instytut Biologii Doświadczalnej Im. Marcelego Nenckiego Pan
Priority to PL405046A priority Critical patent/PL405046A1/pl
Priority to EP14789607.0A priority patent/EP3033621A2/en
Priority to JP2016533982A priority patent/JP2016526926A/ja
Priority to CN201480047715.0A priority patent/CN105593686A/zh
Priority to US14/911,821 priority patent/US9914955B2/en
Priority to PCT/IB2014/063883 priority patent/WO2015022646A2/en
Publication of PL405046A1 publication Critical patent/PL405046A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Wynalazek dotyczy genetycznie zakodowanego, wykorzystującego zjawisko FRET biosensora do monitorowania aktywności metaloproteazy macierzy zewnątrzkomórkowej 9 (MMP-9). MMP-9 jest zewnątrzkomórkową endopeptydazą zaangażowaną zarówno w procesy fizjologiczne i patologiczne. Zakotwiczony w błonie komórkowej, genetycznie zakodowany, wykorzystujący zjawisko FRET, biosensor pozwala na badanie aktywności proteolitycznej MMP-9 z wysoką rozdzielczością czasowo-przestrzenną bezpośrednio w miejscu aktywności MMP-9 na komórce. Funkcjonalność biosensora, zarówno in vitro i in vivo w żywych komórkach została wykazana przy pomocy analizy ratiometrycznej cięcia biosensora przez oczyszczoną auto-aktywującą zmutowaną MMP-9.
PL405046A 2013-08-12 2013-08-12 Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie PL405046A1 (pl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PL405046A PL405046A1 (pl) 2013-08-12 2013-08-12 Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie
EP14789607.0A EP3033621A2 (en) 2013-08-12 2014-08-12 Genetically encoded fret-based mmp-9 activity biosensor and use thereof
JP2016533982A JP2016526926A (ja) 2013-08-12 2014-08-12 遺伝子的にコードしたｆｒｅｔベースのｍｍｐ−９活性バイオセンサおよびその使用
CN201480047715.0A CN105593686A (zh) 2013-08-12 2014-08-12 遗传编码的基于fret的mmp-9活性生物传感器及其用途
US14/911,821 US9914955B2 (en) 2013-08-12 2014-08-12 Genetically encoded FRET-based MMP-9 activity biosensor and use thereof
PCT/IB2014/063883 WO2015022646A2 (en) 2013-08-12 2014-08-12 Genetically encoded fret-based mmp-9 activity biosensor and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL405046A PL405046A1 (pl) 2013-08-12 2013-08-12 Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie

Publications (1)

Publication Number Publication Date
PL405046A1 true PL405046A1 (pl) 2015-02-16

Family

ID=51795665

Family Applications (1)

Application Number Title Priority Date Filing Date
PL405046A PL405046A1 (pl) 2013-08-12 2013-08-12 Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie

Country Status (6)

Country Link
US (1) US9914955B2 (pl)
EP (1) EP3033621A2 (pl)
JP (1) JP2016526926A (pl)
CN (1) CN105593686A (pl)
PL (1) PL405046A1 (pl)
WO (1) WO2015022646A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105572088A (zh) * 2016-01-14 2016-05-11 刘伟 一种检测mmp-9功能的fret生物传感器及其构建方法与应用
KR102018249B1 (ko) * 2017-04-04 2019-09-10 한양대학교 산학협력단 프로테아제 활성 분석용 프로브 및 이를 이용한 분석 방법
KR102195625B1 (ko) * 2018-08-28 2020-12-28 주식회사 제이엘메디랩스 타겟 물질 검출을 위한 방법 및 키트
KR102659088B1 (ko) * 2019-11-18 2024-04-24 서울대학교병원 Mmp 센서 기반의 실시간 구형 구축 모니터링과 치료가 가능한 유방 재건용 조직 확장기 및 이와 연계된 환자 정보 시스템

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935801B2 (en) * 2005-05-20 2011-05-03 The Governors Of The University Of Alberta Teal fluorescent proteins
NO20053354D0 (no) * 2005-07-11 2005-07-11 Amersham Health As Optical imaging contrast agent.
WO2008019123A2 (en) * 2006-08-04 2008-02-14 Georgia State University Research Foundation, Inc. Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
CN100557031C (zh) * 2006-12-27 2009-11-04 华中科技大学 检测基质金属蛋白酶活性的多核苷酸序列
WO2009035476A1 (en) * 2007-09-14 2009-03-19 Biosentinel, Llc Resonance energy transfer assay with cleavage sequence and spacer
US20110171675A1 (en) * 2008-08-04 2011-07-14 Yingxiao Wang Fret-based membrane-type 1 matrix metalloproteinase biosensor and methods for using the same
JP2012177549A (ja) * 2009-06-24 2012-09-13 Hokkaido Univ 蛍光温度プローブおよびそれを用いた温度測定装置
ES2683377T3 (es) * 2011-07-29 2018-09-26 Avelas Biosciences, Inc. Moléculas de suministro selectivo y métodos de uso

Also Published As

Publication number Publication date
JP2016526926A (ja) 2016-09-08
CN105593686A (zh) 2016-05-18
WO2015022646A4 (en) 2015-06-25
US20160194681A1 (en) 2016-07-07
WO2015022646A2 (en) 2015-02-19
US9914955B2 (en) 2018-03-13
WO2015022646A3 (en) 2015-05-07
EP3033621A2 (en) 2016-06-22

Similar Documents

Publication Publication Date Title
PL405046A1 (pl) Genetycznie kodowany oparty na FRET biosensor aktywności MMP-9 i jego zastosowanie
DK3043706T3 (da) Indretning og fremgangsmåde til evaluering og overvågning af fysisk smerte
CO6551732A2 (es) Dispositivo portatil de monitorizaciòn de la coagulación y método de evaluación de la respuesta de coagulación
AR054479A1 (es) Metodo para diagnosticar l a enfermedad de alzheimer
RU2012105922A (ru) Дифференцирование человеческих эмбриональных стволовых клеток
ATE509570T1 (de) Analytisches hilfsmittel mit lanzette und testelement
BR112013014003A2 (pt) Métodos de redução de produção de sebo na pele
ATE494834T1 (de) Säuglingsmonitor
MX2013013905A (es) Ensayo de lisil oxidasa homologo 2 y metodo de uso de la misma.
EA201071324A1 (ru) Система и способы измерения профилей биомаркеров
UY29777A1 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión.
MA38042B2 (fr) Méthylglyoxal en tant que marqueur du cancer
BR112012010252A2 (pt) variantes de glicosilação de anticorpo
DE60231814D1 (de) Diagnostische marker für ischämie und mortalitätsrisiken
WO2007084397A3 (en) Processing of slpi by chymase
CO6430490A2 (es) Biomarcadores de proteina para el diagnostico de enfermedades de tejido blando y como objetivos terapeuticos para intervenciones de cuidado oral
BR112014029808A2 (pt) método para testar o efeito de uma etapa de produção ou etapas de produção ou a eficácia de uma etapa de purificação ou etapas de purificação na presença ou na natureza de moléculas pró-inflamatórias em polímeros de glicose ou hidrolisados dos mesmos; e método otimizado para produzir ou purificar polímeros de glicose ou hidrolisados dos mesmos
BR112013031431A2 (pt) método para o diagnóstico da doença de gaucher
SE0801748L (sv) Anordning vid provtagningsnålar
AR085164A1 (es) Metodos para el analisis de la placa
TR200802195A2 (tr) Yüzeyde zenginleştirilmiş raman saçılmasına dayalı doku farklılaştırma yöntemi.
PE20142280A1 (es) Metodo de tamizaje de la neurogenesis y el sistema que utiliza las celulas madre derivadas del tejido adiposo
BR112013032132A2 (pt) "uso de peptidase da família calicreína, de agente que aumenta a sua expressão ou de células que apresentam expressão ou atividade de rheb reduzida para prevenção ou tratamento de diabetes e distúrbio metabólico e aumento da sensibilidade à insulina, bem como métodos para determinar se composto de teste é agente terapêutico provável no tratamento de diabetes"
RU2009126387A (ru) Способ изучения перцептивных звеньев в структуре функциональных систем, реализующих процессы внимания
Laflamme et al. Study of the bidirectional sensing characteristic of a thin film strain gauge for monitoring of wind turbine blades